HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atique U Ahmed Selected Research

signal sequence receptor

1/2022Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atique U Ahmed Research Topics

Disease

31Neoplasms (Cancer)
11/2022 - 12/2007
27Glioma (Gliomas)
01/2022 - 01/2013
16Glioblastoma (Glioblastoma Multiforme)
11/2022 - 01/2013
14Brain Neoplasms (Brain Tumor)
01/2022 - 01/2012
7Breast Neoplasms (Breast Cancer)
01/2022 - 05/2015
4Neoplasm Metastasis (Metastasis)
01/2022 - 05/2015
4Hypoxia (Hypoxemia)
01/2022 - 01/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 12/2007
2Infections
09/2011 - 03/2011
2Carcinogenesis
11/2008 - 12/2007
1Circulating Neoplastic Cells
12/2019
1Virus Diseases (Viral Diseases)
07/2013
1Hematologic Neoplasms (Hematological Malignancy)
07/2013
1Lentivirus Infections
11/2008
1Lung Neoplasms (Lung Cancer)
11/2008

Drug/Important Bio-Agent (IBA)

8Temozolomide (Temodar)FDA LinkGeneric
11/2022 - 09/2013
6Pharmaceutical PreparationsIBA
01/2022 - 03/2013
5Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 11/2008
3PlasticsIBA
11/2022 - 10/2016
3AntibodiesIBA
01/2022 - 11/2014
3human ERBB2 proteinIBA
01/2022 - 10/2015
2Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2019
2Trastuzumab (Herceptin)FDA Link
01/2022 - 10/2015
2Fatty Acids (Saturated Fatty Acids)IBA
10/2020 - 01/2019
2TubulinIBA
01/2020 - 05/2015
2AntigensIBA
10/2018 - 03/2011
2SurvivinIBA
01/2016 - 09/2015
2Peptides (Polypeptides)IBA
09/2015 - 12/2014
2AgarIBA
11/2008 - 12/2007
1tucatinibIBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1pertuzumabIBA
01/2022
1olfactomedinIBA
01/2022
1signal sequence receptorIBA
01/2022
1taxaneIBA
01/2022
1Paclitaxel (Taxol)FDA LinkGeneric
01/2022
1purineIBA
01/2021
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2020
1Single-Domain AntibodiesIBA
12/2019
1Fatty Acid-Binding Protein 7IBA
01/2019
1ChromatinIBA
01/2019
1Dopamine (Intropin)FDA LinkGeneric
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1LipidsIBA
01/2019
1MethyltransferasesIBA
01/2019
1Dopamine Receptors (Dopamine Receptor)IBA
01/2019
1IntegrinsIBA
01/2019
1Interleukin-8 (Interleukin 8)IBA
01/2019
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2019
1Pyruvic Acid (Pyruvate)IBA
01/2019
1OsteoprotegerinIBA
10/2016
1ChemokinesIBA
10/2016
1VaccinesIBA
07/2015
1NestinIBA
05/2015
1Antiviral Agents (Antivirals)IBA
02/2015
1GD3 ganglioside (GD(3))IBA
12/2014
1Contrast MediaIBA
12/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2014
1Trans-Activators (Trans-Acting Factor)IBA
12/2014
1GoldIBA
12/2014
1EnzymesIBA
01/2014
1Heme Oxygenase-1IBA
01/2014
1TNF-Related Apoptosis-Inducing LigandIBA
01/2014
1Oxyquinoline (8 Hydroxyquinoline)FDA Link
01/2014
1AntioxidantsIBA
11/2013
1Sulfhydryl Compounds (Thiols)IBA
11/2013
1N-AcetylcysteinamideIBA
11/2013
1LigandsIBA
03/2013
1CytokinesIBA
01/2013
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
11/2012
1Chemotactic FactorsIBA
09/2011
1Peptide Hydrolases (Proteases)FDA Link
11/2008
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
11/2008
1Small Interfering RNA (siRNA)IBA
11/2008
1Uridine Triphosphate (UTP)IBA
11/2008
1ErbB Receptors (EGF Receptor)IBA
11/2008
1Monomeric GTP-Binding ProteinsIBA
12/2007
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2007

Therapy/Procedure

25Therapeutics
11/2022 - 10/2010
10Drug Therapy (Chemotherapy)
11/2022 - 09/2013
5Oncolytic Virotherapy
01/2016 - 03/2010
4Radiotherapy
11/2022 - 01/2012
1Immunotherapy
11/2022
1RNAi Therapeutics
01/2017
1Biological Therapy
01/2016
1Intravenous Administration
12/2014
1Injections
11/2008